Responses of human, monkey and dog coronary arteries in vitro to carbocyclic thromboxane A2 and vasodilators
- 1 October 1984
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 83 (2) , 399-408
- https://doi.org/10.1111/j.1476-5381.1984.tb16500.x
Abstract
Carbocyclic thromboxane A2 (cTxA2), a stable analog of TxA2, and prostaglandin (PG) F2.alpha. contracted helical strips of human, monkey and dog coronary arteries in a concentration-dependent manner. Apparent ED50 values for cTxA2 were markedly less (1/58 in humans, 1/373 in monkeys and 1/397 in dogs) than those for PGF2.alpha.. Maximum contractions induced by cTxA2 and PGF2.alpha. relative to those induced by 30 mM K+ were approximately identical in the human and monkey arteries. PGI2 [prostacyclin] caused a concentration-related relaxation in human and dog coronary arteries maximally precontracted with cTxA2 and in human, monkey and dog coronary arteries partially precontracted with PGF2.alpha.. The relaxation response was greatest in the dog arteries and least in the monkey arteries. Contractions induced by cTxA2 or PGF2.alpha. and relaxations induced by PGI2 were selectively antagonized by treatment with diphloretin phosphate. Human coronary artery strips contracted with cTxA2 responded to nitroglycerin with a rapid, transient relaxation and to verapamil with a slowly developing, persistent relaxation, as did monkey and dog coronary artery strips. Thromboxane (Tx) A2 appears to be one of the most potent endogenous vasoconstrictors in human coronary arteries, if cTxA2 acts on TxA2 receptors. Apparently PGI2, nitroglycerin and verapamil are effective vasodilators in human conduit coronary arteries maximally contracted with cTxA2, although the extent and the duration of vasodilation induced by these agents were quite different.This publication has 31 references indexed in Scilit:
- Comparison of the Inhibitory Effects of Nifedipine, Nitroglycerin, and Nitroprusside Sodium on Different Types of Activation in Canine Coronary Arteries, with Comparative Studies in Human Coronary ArteriesJournal of Cardiovascular Pharmacology, 1983
- Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris.Circulation, 1981
- Coronary Vasoconstrictor Effect of Indomethacin in Patients with Coronary-Artery DiseaseNew England Journal of Medicine, 1981
- Exercise-induced angina provoked by aspirin administration in patients with variant anginaThe American Journal of Cardiology, 1981
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- Prostaglandins, their intermediates and precursors: Cardiovascular actions and regulatory roles in normal and abnormal circulatory systemsProgress in Cardiovascular Diseases, 1979
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- Responses of isolated dog cerebral and peripheral arteries to prostaglandins after application of aspirin and polyphloretin phosphate.Stroke, 1978
- Cerebral arterial smooth muscle contraction by thromboxane A2.Stroke, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976